drugset / Trial / NCT05127746
Phase 1 Clinical Trial of DA-5207 in Healthy Adults
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics of DA-5207 transdermal delivery system in healthy adults
Timeline
- Start
- 2021-11-25
- Primary completion
- 2022-12-13
- Completion
- 2022-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-5207 | Unknown | — | Other |
| Subject | Donepezil | Small molecule | 5 mg | — |
| Subject | Donepezil | Small molecule | 10 mg | — |
Indications
No indication recorded.